BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 27861784)

  • 1. Focus on cannabinoids and synthetic cannabinoids.
    Le Boisselier R; Alexandre J; Lelong-Boulouard V; Debruyne D
    Clin Pharmacol Ther; 2017 Feb; 101(2):220-229. PubMed ID: 27861784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic cannabinoids: analysis and metabolites.
    Elsohly MA; Gul W; Wanas AS; Radwan MM
    Life Sci; 2014 Feb; 97(1):78-90. PubMed ID: 24412391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
    Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2015 Aug; 6(8):1445-58. PubMed ID: 25921407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid signaling in health and disease.
    Lu Y; Anderson HD
    Can J Physiol Pharmacol; 2017 Apr; 95(4):311-327. PubMed ID: 28263083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doors of deception: the diaspora of designer drugs.
    Kerwin J
    Drug Test Anal; 2011 Sep; 3(9):527-31. PubMed ID: 21960538
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.
    Pacher P; Steffens S; Haskó G; Schindler TH; Kunos G
    Nat Rev Cardiol; 2018 Mar; 15(3):151-166. PubMed ID: 28905873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K; Goś R
    Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
    De Luca MA; Fattore L
    Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids.
    López-Rodríguez ML
    Mini Rev Med Chem; 2005 Jul; 5(7):607. PubMed ID: 16026306
    [No Abstract]   [Full Text] [Related]  

  • 11. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.
    Marusich JA; Wiley JL; Lefever TW; Patel PR; Thomas BF
    Neuropharmacology; 2018 May; 134(Pt A):73-81. PubMed ID: 29113898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
    Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
    Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.
    Angerer V; Mogler L; Steitz JP; Bisel P; Hess C; Schoeder CT; Müller CE; Huppertz LM; Westphal F; Schäper J; Auwärter V
    Drug Test Anal; 2018 Mar; 10(3):597-603. PubMed ID: 28670781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic neuroanatomy and neuropharmacology of cannabinoids.
    Breivogel CS; Sim-Selley LJ
    Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical basis of cannabis addiction.
    Maldonado R; Berrendero F; Ozaita A; Robledo P
    Neuroscience; 2011 May; 181():1-17. PubMed ID: 21334423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid signalling in the enteric nervous system.
    Galligan JJ
    Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.